Classification of the incidence of adverse events according to recommendations
World Health Organization (WHO):
very often ≥1 / 10;
often from ≥ 1/100 to <1/10;
infrequently from ≥ 1/1000 to <1/100;
rarely from ≥ 1/10000 to <1/1000;
very rarely <1/10000, including individual messages;
the frequency is unknown - it is not possible to establish the frequency of occurrence from the available data.
Infectious and parasitic diseases: rarely - folliculitis, a secondary infection.
Disturbances from the skin and subcutaneous tissues: rarely - skin irritation, dry skin, burning sensation of the skin, itching, hypertrichosis, acne, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, skin atrophy, striae, sweat, papules, pustules.
Impaired nervous system: frequency is unknown - paresthesia.
When using external forms of GCS for a long time and / or when applied to large areas of the skin, or with the use of occlusive dressings, especially in children and adolescents, side effects, characteristic of SCS of systemic action, may occur, including adrenal insufficiency and Isenko-Cushing syndrome.